MediPharm Labs Corp.
LABS.TOTSXHealthcare● Active
$0.07
+$0.00(+0.00%)
Market Cap$29740480
P/E Ratio—
52W High$0.1
52W Low$0.06
MediPharm Labs Corp. (LABS.TO) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · LABS.TO · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $45.12M | $41.96M | $33.06M | $22.12M | $21.71M |
| Cost of Revenue | $31.16M | $29.16M | $27.21M | $24.03M | $36.96M |
| Gross Profit | $13.97M | $12.80M | $5.86M | ($1.91M) | ($15.25M) |
| Gross Margin %(computed) | 30.95% | 30.52% | 17.71% | -8.65% | -70.22% |
| Operating Expenses | |||||
| R&D Expenses | $0.22M | $0.23M | $0.21M | $1.00M | $1.35M |
| G&A Expenses | $18.58M | $19.81M | $21.64M | $18.45M | $18.40M |
| Total Operating Expenses | $22.38M | $23.61M | $24.11M | $26.88M | $27.76M |
| Operating Income | ($8.41M) | ($10.81M) | ($18.25M) | ($29.53M) | ($48.92M) |
| Operating Margin %(computed) | -18.63% | -25.76% | -55.21% | -133.53% | -225.31% |
| Interest Income | $0.23M | $0.69M | $0.84M | $0.48M | $0.23M |
| Interest Expense | $0.06M | $0.58M | $0.36M | $0.03M | $10.51M |
| Income Before Tax | ($8.27M) | ($10.69M) | ($13.36M) | ($29.99M) | ($54.69M) |
| Income Tax Expense | $0.00M | $0.00M | ($0.28M) | ($0.01M) | $0.11M |
| Net Income | ($8.27M) | ($10.69M) | ($13.08M) | ($29.98M) | ($54.80M) |
| Net Margin %(computed) | -18.32% | -25.49% | -39.57% | -135.57% | -252.41% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.02 | $-0.03 | $-0.04 | $-0.11 | $-0.22 |
| Wtd Avg Shares | 420.76M | 407.99M | 363.32M | 276.86M | 249.91M |
| EBITDA | ($6.54M) | ($7.52M) | ($10.48M) | ($27.09M) | ($38.55M) |
| EBITDA Margin %(computed) | -14.50% | -17.92% | -31.69% | -122.47% | -177.56% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · CAD · M
Explore more MediPharm Labs Corp. data
About MediPharm Labs Corp. (LABS.TO) Income Statement
MediPharm Labs Corp. (LABS.TO) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, LABS.TO reported revenue of $0.05B, gross profit of $0.01B (gross margin 30.95%), and net income of ($0.01B) — a net profit margin of -18.32%.
Frequently asked questions
LABS.TO · 4 questionsMediPharm Labs Corp. (LABS.TO) reported revenue of $0.05B for 2025, up 7.5% year-over-year.
LABS.TO revenueLABS.TO salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08